Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$72.2K Buy
562
+462
+462% +$54.1K 0.05% 57
2026
Q1
$12K Hold
100
0.01% 121
2025
Q4
$10.5K Buy
+100
New +$9.39K 0.01% 130

Other funds holding MRK

NorthAvenue LLC's MRK Position: Q2 2026 in Review

NorthAvenue LLC increased its Merck (MRK) stake by 462% in Q2 2026, buying an estimated $54.1K and bringing the position to 562 shares worth $72.2K. The position accounts for 0.05% of the portfolio, ranked #57.

NorthAvenue LLC first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. 1,532 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • NorthAvenue LLC held 562 shares of Merck worth $72.2K as of Q2 2026.
  • NorthAvenue LLC bought 462 Merck shares in Q2 2026, an estimated $54.1K.
  • Merck made up 0.05% of NorthAvenue LLC's portfolio in Q2 2026, its #57 holding.
  • NorthAvenue LLC first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
  • 1,532 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on NorthAvenue LLC's 13F filing for Q2 2026, filed 21 Jul 2026.